Targeting microbubbles
US-2016367669-A1 · Dec 22, 2016 · US
Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid · Cooperative Patent Classification (CPC)
Agriculture, food, personal care, health, and life sciences.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | A61K31/663 |
| Official title | Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid |
| Display label | Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid |
| Total patents | 419 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 30 |
| 2016 | 60 |
| 2017 | 70 |
| 2018 | 77 |
| 2019 | 53 |
| 2020 | 25 |
| 2021 | 30 |
| 2022 | 24 |
| 2023 | 14 |
| 2024 | 19 |
| 2025 | 14 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US-9517242-B2 · Dec 13, 2016 · US
Composition and method for treating a hematological malignancy
US-9518300-B2 · Dec 13, 2016 · US
Precise delivery of therapeutic agents to cell mitochondria for anti-cancer therapy
US-2016339106-A1 · Nov 24, 2016 · US
Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
US-2016331768-A1 · Nov 17, 2016 · US
Osteoclast inhibitors for bone marrow lesions
US-2016331767-A1 · Nov 17, 2016 · US
Osteoclast Inhibitors for Joint Conditions
US-2016331766-A1 · Nov 17, 2016 · US
Trk-inhibiting compound
US-9463192-B2 · Oct 11, 2016 · US
Cell-free tissued engineered vascular grafts
US-2016271152-A1 · Sep 22, 2016 · US
Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
US-2016256517-A1 · Sep 8, 2016 · US
Enteric soft capsules
US-9433585-B2 · Sep 6, 2016 · US
Treating inflammation using llp2a-bisphosphonate conjugates and mesenchymal stem cells
US-2016243250-A1 · Aug 25, 2016 · US
Methods to modulate Rac1 import and to treat pulmonary fibrosis
US-9416149-B2 · Aug 16, 2016 · US
Osteoclast inhibitors for knee conditions
US-9408861-B2 · Aug 9, 2016 · US
Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
US-9408860-B2 · Aug 9, 2016 · US
Osteoclast Inhibitors for Knee Conditions
US-2016199394-A1 · Jul 14, 2016 · US
Methods of promoting fat loss comprising administering an alk7 inhibitor
US-2016199458-A1 · Jul 14, 2016 · US
Osteoclast Inhibitors Such as Zoledronic Acid for Low Back Pain Treatment
US-2016166589-A1 · Jun 16, 2016 · US
Dosage Forms for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
US-2016158256-A1 · Jun 9, 2016 · US
Synergistic antimicrobial composition
US-2016150791-A1 · Jun 2, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC A61K31/663?
- CPC A61K31/663 is the Cooperative Patent Classification code for “Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid.”
- How many patents are filed under CPC A61K31/663 (Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid)?
- Our database includes 419 publications tagged with this CPC code.
- Is patent activity under CPC A61K31/663 growing?
- Publication counts under this code: 19 in 2024 vs 14 in 2025 (latest complete years).